Despite COVID Vaccinations, Caution Still Crucial for Transplant Recipients

Note: This article was updated to include information from a Hopkins study published on May 5, 2021, of responses after a second vaccine dose was given to transplant patients. Long before COVID-19 changed the world, organ transplant recipients were wearing masks to shield themselves from airborne threats. Immunosuppressive medicines, which often…

Enrollment for Phase 2b Trial of Verona’s COPD Therapy RPL554 Is Ahead of Schedule

Verona Pharma has enrolled more than half of the 400 COPD patients it is seeking for a Phase 2b clinical trial of its therapy candidate RPL554, putting the program ahead of schedule. This means the company may be able to report the results of the study by mid-2018, sooner than expected. The…